Global Brain has invested in Cykinso, Inc. (Cykinso), a company offering personalized healthcare recommendations based on bacterial flora data, through its KIRIN HEALTH INNOVATION FUND. Cykinso is a company that analyzes people’s life data such as bacterial flora data and lifestyle habits and develops personalized healthcare services. The company has one of the largest databases of intestinal flora tests in Japan, with a total of over 100,000 samples as of October 2023. The company is striving to improve people’s health by recommending personalized healthcare solutions to its customers based on its extensive database and proprietary metrics. Global Brain has decided to invest in Cykinso, highly recognizing the potential of the bacterial flora market as well as Cykinso's database and testing analysis know-how. Through this investment, Global Brain will contribute to the business expansion of Cykinso in collaboration with Kirin Holdings which has substantial expertise in intestinal flora.

About Cykinso

Location: Shibuya-ku, Tokyo, Japan
Representative: Yu Sawai
Founded: November 2014
URL: https://cykinso.co.jp/
(Available only in Japanese)

About KIRIN HEALTH INNOVATION FUND

Name: KIRIN-GB Fund I L.P.
General Partner: Global Brain Corporation
Fund Size: JPY 5 billion
Fund Term: 10 years

About Global Brain

Location: Tokyo, Japan
Representative: Yasuhiko Yurimoto
Founded: January 1998
URL: https://globalbrains.com/

Global Brain has invested in Cykinso, Inc., a company offering personalized healthcare recommendations based on bacterial flora data